Updated Vasculitis Recommendations Include New Drugs, Practices

Avacopan and mepolizumab feature in new European recommendations for managing antineutrophil cytoplasmic antibody-associated vasculitis.

Related Keywords

Germany ,Berlin ,German ,Julia Holle ,Rheumazentrum Schleswig Holstein Mitte ,Bernhard Hellmich ,Bristol Myers Squibb ,Andreas Krause ,Glaxosmithkline ,Amgen ,European Congress ,German Society For Rheumatology ,Boehringer Ingelheim ,Novartis ,European Alliance Of Associations ,Pfizer ,Astrazeneca ,European Alliance ,Unchanged Recommendations ,German Society ,Immanuel Hospital ,Berlin Andreas Krause ,Merck Sharp ,Vasculitis ,Asthma ,Sthmatic ,Churg Strauss Syndrome ,Llergic Granulomatosis ,Llergic Granulomatous Angiitis ,Hurg Strauss Disease ,Wegeners Granulomatosis ,Wegener Granulomatosis ,Biologic Therapy ,Monoclonal Antibody ,Etuximab ,Ituximab ,Europe ,European ,Steroids ,Glucocorticosteroids ,Hospitals ,Adverse Effects ,Side Effects ,Clinical Guidelines ,Guidelines ,Microscopic Polyangiitis ,Patient Safety ,